Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Saturn Oil & Gas Inc. Announces its First Development of Cardium Wells at Brazeau and Continued Successful Development (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Lantheus Holdings Inc LNTH

Healthcare Medical Instruments & Supplies
Lantheus Holdings, Inc. is a radiopharmaceutical-focused company. The Company is engaged in delivering science to enable clinicians to find, fight and follow disease to deliver patient outcomes. The Company classifies its products in three categories: Radiopharmaceutical Oncology, Precision Diagnostics, and Strategic Partnerships. Its Radiopharmaceutical Oncology diagnostics and therapeutic... see more

Recent & Breaking News (NDAQ:LNTH)

Lantheus Expands R&D Leadership Team with Key New Hires

Business Wire April 7, 2021

Lantheus Announces Retirement of Michael P. Duffy, Senior Vice President and General Counsel

Business Wire April 1, 2021

Lantheus Acquires Rights to Innovative Imaging Biomarker Targeting Fibroblast Activation Protein (FAP) from Noria

Business Wire March 30, 2021

Lantheus Announces Presentation Featuring AZEDRA® (iobenguane I 131) at ENDO 2021

Business Wire March 22, 2021

Lantheus Announces Publication of PyL(TM) (18F-DCFPyL) Results from Pivotal Studies

Business Wire March 1, 2021

Lantheus Reports Fourth Quarter and Full Year 2020 Financial Results

Business Wire February 25, 2021

Lantheus Holdings to Present at the 10th Annual SVB Leerink Global Healthcare Conference

Business Wire February 12, 2021

Lantheus Holdings to Host Fourth Quarter and Full Year 2020 Earnings Conference Call and Webcast on February 25, 2020 at 4:30 p.m. Eastern Time

Business Wire February 11, 2021

Lantheus Holdings Announces Presentations Featuring its PSMA-Targeted Pipeline Product Candidates at the 2021 ASCO GU Annual Meeting

Business Wire February 4, 2021

Lantheus Holdings Announces Submission of Drug Master File for NM-01 in the U.S.

Business Wire January 12, 2021

Lantheus Holdings Announces Acceptance and Priority Review of New Drug Application for PyLTM (18F-DCFPyL), a PSMA-Targeted Prostate Cancer PET Imaging Agent

Business Wire December 9, 2020

PyL(TM) (18F-DCFPyL), Lantheus' PSMA-Targeted Prostate Cancer Imaging Agent, to be Used in POINT Biopharma's PSMA-Targeted Radioligand Therapeutic Phase 3 Trial in Patients with Metastatic Castration Resistant Prostate Cancer

Business Wire December 9, 2020

Lantheus Holdings, Inc. Announces Agreement to Sell Its Puerto Rico Radiopharmacy and PET Manufacturing Facility and Enter into Long-Term Supply Agreement

Business Wire December 3, 2020

Lantheus Holdings to Present at the 2020 Evercore ISI HealthCONx Conference

Business Wire November 24, 2020

Lantheus Holdings, Inc. Announces FDA Approval of DEFINITY® Room Temperature

Business Wire November 18, 2020

Lantheus Holdings Announces FDA Clearance for AI-Enabled Automated Bone Scan Index (aBSI) in Prostate Cancer on GE Healthcare's Xeleris Platform

Business Wire November 13, 2020

CORRECTION: TIME CHANGE - Lantheus Holdings to Present at November 2020 Investor Conferences

Business Wire November 9, 2020

Lantheus Holdings, Inc. Reports Third Quarter 2020 Financial Results

Business Wire November 5, 2020

Lantheus Holdings to Present at November 2020 Investor Conferences

Business Wire November 4, 2020

Lantheus Enters into Strategic Collaboration with Insightec for Use of Microbubbles in Combination with MR-Guided Focused Ultrasound for Treatment of Glioblastoma and Neurodegenerative Conditions

Business Wire October 29, 2020